Cancer Panels

The Division of Genomic Diagnostics at Children’s Hospital of Philadelphia has launched a series of hereditary and somatic cancer gene panels to facilitate a precision medicine approach to cancer diagnostics. Genetic alterations identified by these panels will facilitate diagnosis, determine prognosis, stratify patient risk, inform treatment decisions, and evaluate patients’ eligibility for clinical trials.

• Comprehensive Solid Tumors Panel (Solid + Fusion)
• Solid Tumor Panel
• Comprehensive Hematological Cancer Panel (Heme + Fusion)
• Hematological Cancer Panel
• Fusion Gene Panel
• Cancer Transcriptome Analysis (RNA Sequencing)

• Paired Tumor / Normal – Comprehensive Hematologic Cancer Panel
• Paired Tumor / Normal – Hematologic Cancer Panel
• Paired Tumor / Normal – Comprehensive Solid Tumor Panel
• Paired Tumor / Normal – Solid Tumor Panel

• Comprehensive Hereditary Cancer Panel
• Hereditary Breast/Gyn Cancer Panel
• Hereditary High-Risk Breast Cancer
• Hereditary High-Risk Colorectal Panel
• Hereditary Leukemia/Lymphoma Panel
• Hereditary Paraganglioma/Pheo Panel

• Comprehensive BMF/MDS/Leukemia Predisposition Panel
• Bone Marrow Failure Panel
• Fanconi Anemia NGS Panel
• Inherited Neutropenia Panel
• Inherited Red Blood Cell Disorder Panel
• Inherited Thrombocytopenia Panel
• Telomere Disorder Panel

To order cancer testing, please download and fill out our Cancer Test Request Form.

For more information, contact Jason Roberts, Manager, Strategic Business Development, Division of Pathology and Laboratory Medicine, at 215-590-0637 or robertsj1@email.chop.edu.